Al Altomari
2019
In 2019, Al Altomari earned a total compensation of $1.3M as Chairman & Chief Executive Officer at Agile Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $441,000 |
|---|---|
| Option Awards | $330,266 |
| Salary | $506,733 |
| Other | $23,372 |
| Total | $1,301,371 |
Altomari received $506.7K in salary, accounting for 39% of the total pay in 2019.
Altomari also received $441K in non-equity incentive plan, $330.3K in option awards and $23.4K in other compensation.
Rankings
In 2019, Al Altomari's compensation ranked 8,021st out of 13,971 executives tracked by ExecPay. In other words, Altomari earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,021 out of 13,971 | 43rd |
Division Manufacturing | 3,162 out of 5,695 | 45th |
Major group Chemicals And Allied Products | 1,201 out of 2,194 | 45th |
Industry group Drugs | 1,023 out of 1,880 | 46th |
Industry Pharmaceutical Preparations | 761 out of 1,392 | 45th |
Source: SEC filing on April 24, 2020.
Altomari's colleagues
We found two more compensation records of executives who worked with Al Altomari at Agile Therapeutics in 2019.